Wall Street analysts expect M/A-Com (MTSI) to post quarterly earnings of $0.89 per share in its upcoming report, which indicates a year-over-year increase of 34.9%. Revenues are expected to be $250.06 million, up 31.3% from the year-ago quarter. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe. Before a company reveals its earnings, it is vital to take ...

Wall Street analysts forecast that Wolverine World Wide (WWW) will report quarterly earnings of $0.22 per share in its upcoming release, pointing to a year-over-year increase of 46.7%. It is anticipated that revenues will amount to $446.48 million, exhibiting an increase of 5% compared to the year-ago quarter. According to the collective judgment of analysts, 'Revenue- Work Group' should come in at $104.03 million. The estimate suggests a change of -0.9% year over year. View all Key Company Metrics for Wolv ...

Wall Street analysts forecast that Caterpillar (CAT) will report quarterly earnings of $4.30 per share in its upcoming release, pointing to a year-over-year decline of 23.2%. It is anticipated that revenues will amount to $14.54 billion, exhibiting a decline of 8% compared to the year-ago quarter.The consensus EPS estimate for the quarter has undergone a downward revision of 2.3% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed the ...

季度业绩预测 - 华尔街分析师预计Ecolab季度每股收益(EPS)为1.51美元 同比增长12.7% [1] - 季度营收预计达37亿美元 同比下滑1.4% [1] - 过去30天内共识EPS预测上调0.2% 反映分析师持续修正预期 [2] 关键业务指标预测 销售收入 - 全球医疗与生命科学业务(固定汇率)销售额预计2.5492亿美元 同比暴跌33.4% [5] - 全球工业业务(公开汇率)销售额预计18.4亿美元 微增0.3% [5] - 全球机构与专业业务(公开汇率)销售额预计12.9亿美元 增长1.8% [6] - 全球机构与专业业务(固定汇率)销售额预计13.7亿美元 显著增长7.9% [6] - 全球工业业务(固定汇率)销售额预计19.2亿美元 增长4.1% [6] - 全球医疗与生命科学业务(公开汇率)销售额预计2.8691亿美元 下降24.5% [7] 营业利润 - 全球工业业务(固定汇率)营业利润预计3.0298亿美元 较去年同期的2.65亿美元显著提升 [7] - 全球机构与专业业务(固定汇率)营业利润预计2.7946亿美元 高于去年同期的2.48亿美元 [8] - 全球医疗与生命科学业务(固定汇率)营业利润预计3071万美元 低于去年同期的3700万美元 [8] - 全球机构与专业业务(公开汇率)营业利润预计2.831亿美元 较去年2.47亿美元明显增长 [9] - 全球医疗与生命科学业务(公开汇率)营业利润预计3269万美元 低于去年3630万美元 [9] - 全球工业业务(公开汇率)营业利润预计3.0055亿美元 高于去年2.654亿美元 [10] 市场表现 - 公司股价过去一个月下跌5.7% 同期标普500指数下跌5.1% [11] - 当前Zacks评级为3级(持有) 预计未来表现与大盘同步 [11]